Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:40:52.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 and the previous revision v3.5.0 has been removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:35:20.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:08:57.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3; Removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:52:52.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 notice about government funding and operating status.
    Difference
    0.4%
    Check dated 2026-02-11T12:14:27.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status was added. The page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:30.000Z thumbnail image

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.